Skip to Content

Virtus LifeSci Biotech Products ETF BBP

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBP

Will BBP outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Virtus LifeSci Biotech Products ETF's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBP

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 26.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Lexicon Pharmaceuticals Inc

3.52 637,344
Healthcare

Tarsus Pharmaceuticals Inc Ordinary Shares

2.99 540,834
Healthcare

Sarepta Therapeutics Inc

2.60 471,165
Healthcare

Agios Pharmaceuticals Inc

2.56 463,048
Healthcare

SpringWorks Therapeutics Inc Ordinary Shares

2.55 462,023
Healthcare

CRISPR Therapeutics AG

2.41 435,320
Healthcare

Ascendis Pharma A/S ADR

2.39 432,930
Healthcare

Ironwood Pharmaceuticals Inc Class A

2.37 429,329
Healthcare

Apellis Pharmaceuticals Inc

2.37 428,006
Healthcare

ADMA Biologics Inc

2.35 424,708
Healthcare